Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BREAST CANCER PREDICTIVE GENETIC TESTING INDUSTRY
2.1 Summary about Breast Cancer Predictive Genetic Testing Industry
2.2 Breast Cancer Predictive Genetic Testing Market Trends
2.2.1 Breast Cancer Predictive Genetic Testing Production & Consumption Trends
2.2.2 Breast Cancer Predictive Genetic Testing Demand Structure Trends
2.3 Breast Cancer Predictive Genetic Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 High Penetrant Genes
4.2.2 Intermediate Penetrant Genes
4.2.3 Low Penetrant Genes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 High Penetrant Genes
5.2.2 Intermediate Penetrant Genes
5.2.3 Low Penetrant Genes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 High Penetrant Genes
6.2.2 Intermediate Penetrant Genes
6.2.3 Low Penetrant Genes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 High Penetrant Genes
7.2.2 Intermediate Penetrant Genes
7.2.3 Low Penetrant Genes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 High Penetrant Genes
8.2.2 Intermediate Penetrant Genes
8.2.3 Low Penetrant Genes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 High Penetrant Genes
9.2.2 Intermediate Penetrant Genes
9.2.3 Low Penetrant Genes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche
10.1.2 Thermo Fisher Scientific
10.1.3 PerkinElmer
10.1.4 Quest Diagnostics
10.1.5 Myriad Genetics
10.1.6 Iverson Genetics
10.1.7 Cancer Genetics
10.1.8 OncoCyte Corporation
10.1.9 NeoGenomics
10.1.10 Invitae
10.2 Breast Cancer Predictive Genetic Testing Sales Date of Major Players (2017-2020e)
10.2.1 Roche
10.2.2 Thermo Fisher Scientific
10.2.3 PerkinElmer
10.2.4 Quest Diagnostics
10.2.5 Myriad Genetics
10.2.6 Iverson Genetics
10.2.7 Cancer Genetics
10.2.8 OncoCyte Corporation
10.2.9 NeoGenomics
10.2.10 Invitae
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Breast Cancer Predictive Genetic Testing Product Type Overview
Table Breast Cancer Predictive Genetic Testing Product Type Market Share List
Table Breast Cancer Predictive Genetic Testing Product Type of Major Players
Table Brief Introduction of Roche
Table Brief Introduction of Thermo Fisher Scientific
Table Brief Introduction of PerkinElmer
Table Brief Introduction of Quest Diagnostics
Table Brief Introduction of Myriad Genetics
Table Brief Introduction of Iverson Genetics
Table Brief Introduction of Cancer Genetics
Table Brief Introduction of OncoCyte Corporation
Table Brief Introduction of NeoGenomics
Table Brief Introduction of Invitae
Table Products & Services of Roche
Table Products & Services of Thermo Fisher Scientific
Table Products & Services of PerkinElmer
Table Products & Services of Quest Diagnostics
Table Products & Services of Myriad Genetics
Table Products & Services of Iverson Genetics
Table Products & Services of Cancer Genetics
Table Products & Services of OncoCyte Corporation
Table Products & Services of NeoGenomics
Table Products & Services of Invitae
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Breast Cancer Predictive Genetic Testing Market Forecast (Million USD) by Region 2021f-2026f
Table Global Breast Cancer Predictive Genetic Testing Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Breast Cancer Predictive Genetic Testing Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Breast Cancer Predictive Genetic Testing Market Forecast (Million USD) Share by Demand 2021f-2026f